Published in Cardiol Rev on August 18, 2008
Role of autophagy in angiogenesis in aortic endothelial cells. Am J Physiol Cell Physiol (2011) 1.21
Vascular endothelial growth factor (VEGF)-A: role on cardiac angiogenesis following myocardial infarction. Microvasc Res (2010) 1.19
Sirt3 is essential for apelin-induced angiogenesis in post-myocardial infarction of diabetes. J Cell Mol Med (2014) 0.96
Acidic and basic fibroblast growth factors involved in cardiac angiogenesis following infarction. Int J Cardiol (2010) 0.91
Endothelial fibroblast growth factor receptor signaling is required for vascular remodeling following cardiac ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol (2016) 0.76
A bouquet for a broken heart: can flowers repair a damaged heart? Circ Res (2015) 0.75
Therapeutic angiogenesis promotes efficacy of human umbilical cord matrix stem cell transplantation in cardiac repair. Iran J Basic Med Sci (2015) 0.75
Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle. Proc Natl Acad Sci U S A (2003) 6.82
Comparison of self-report, hospital discharge codes, and adjudication of cardiovascular events in the Women's Health Initiative. Am J Epidemiol (2004) 3.53
TRB3 links the E3 ubiquitin ligase COP1 to lipid metabolism. Science (2006) 3.26
Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab. Circ Cardiovasc Imaging (2012) 2.72
Allergen immunotherapy: a practice parameter third update. J Allergy Clin Immunol (2010) 2.11
ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Circulation (2011) 1.97
Early detection and prediction of cardiotoxicity in chemotherapy-treated patients. Am J Cardiol (2011) 1.93
Open-label treatment trial of lithium to target the underlying defect in fragile X syndrome. J Dev Behav Pediatr (2008) 1.91
In vivo quantification of choline compounds in the breast with 1H MR spectroscopy. Magn Reson Med (2003) 1.76
PPAR gamma signaling exacerbates mammary gland tumor development. Genes Dev (2004) 1.58
Angiotensin receptor blockers for management of hypertension. South Med J (2010) 1.54
Compliance with allopurinol therapy among managed care enrollees with gout: a retrospective analysis of administrative claims. J Rheumatol (2004) 1.52
Use of high-resolution microscopy coil MRI for depicting orbital anatomy. Orbit (2008) 1.47
A bridge too far: a critique of the new ACGME duty hour requirements. Am J Med (2012) 1.46
SMRT repression of nuclear receptors controls the adipogenic set point and metabolic homeostasis. Proc Natl Acad Sci U S A (2008) 1.46
Aldosterone and aldosterone antagonism in cardiovascular disease: focus on eplerenone (Inspra). Heart Dis (2003) 1.45
Apolipoprotein A-I mimetic peptides: a potential new therapy for the prevention of atherosclerosis. Cardiol Rev (2010) 1.35
Intravascular device infections: epidemiology, diagnosis, and management. Cardiol Rev (2006) 1.30
Quadricuspid aortic valve: a report of 12 cases and a review of the literature. Echocardiography (2011) 1.28
Estrogen and progestin use and the QT interval in postmenopausal women. Ann Noninvasive Electrocardiol (2004) 1.27
Pathophysiology, diagnosis, and treatment of orthostatic hypotension and vasovagal syncope. Cardiol Rev (2007) 1.17
ST-elevation myocardial infarction in the elderly--temporal trends in incidence, utilization of percutaneous coronary intervention and outcomes in the United States. Int J Cardiol (2013) 1.16
Inflammation and atherosclerosis: a review of the role of interleukin-6 in the development of atherosclerosis and the potential for targeted drug therapy. Cardiol Rev (2014) 1.15
Cardiovascular complications of eating disorders. Cardiol Rev (2006) 1.15
Cardiovascular drug therapy in the elderly: benefits and challenges. Nat Rev Cardiol (2010) 1.13
A comparison of four dietary assessment methods in materially deprived households in England. Public Health Nutr (2007) 1.13
Neuropsychiatric effects of cardiovascular drug therapy. Cardiol Rev (2003) 1.12
Treatment of hypertension and prevention of ischemic stroke. Curr Cardiol Rep (2004) 1.11
Vascular Ehlers-Danlos syndrome: pathophysiology, diagnosis, and prevention and treatment of its complications. Cardiol Rev (2011) 1.09
Myocardial regeneration and stem cell repair. Curr Probl Cardiol (2008) 1.08
Operationalizing the internal medicine milestones-an early status report. J Grad Med Educ (2013) 1.07
Trends in incidence, management, and outcomes of cardiogenic shock complicating ST-elevation myocardial infarction in the United States. J Am Heart Assoc (2014) 1.06
Protein kinase C in cardiac disease and as a potential therapeutic target. Cardiol Rev (2004) 1.06
Food balance sheet and household budget survey dietary data and mortality patterns in Europe. Br J Nutr (2008) 1.06
The National School Fruit Scheme produces short-term but not longer-term increases in fruit consumption in primary school children. Br J Nutr (2005) 1.05
Targeting heme oxygenase: therapeutic implications for diseases of the cardiovascular system. Cardiol Rev (2009) 1.04
Accuracy of estimates of food portion size using food photographs--the importance of using age-appropriate tools. Public Health Nutr (2006) 1.04
Pharmacologic inhibition of squalene synthase and other downstream enzymes of the cholesterol synthesis pathway: a new therapeutic approach to treatment of hypercholesterolemia. Cardiol Rev (2009) 1.04
Association of ankle-brachial index with severity of angiographic coronary artery disease in patients with peripheral arterial disease and coronary artery disease. Cardiology (2005) 1.03
Carcinoid heart disease. Cardiol Rev (2012) 1.03
Glycaemic index and glycaemic load of breakfast predict cognitive function and mood in school children: a randomised controlled trial. Br J Nutr (2011) 1.02
Cardiac and pericardial tumors. Cardiol Rev (2012) 1.01
U.S. medical students' perceptions of the adequacy of their schools' curricular attention to care at the end of life: 1998-2006. J Palliat Med (2008) 1.01
Type 5 phosphodiesterase inhibitors in the treatment of erectile dysfunction and cardiovascular disease. Cardiol Rev (2007) 1.00
HDL metabolism and CETP inhibition. Cardiol Rev (2008) 1.00
Cardiac amyloidosis: approaches to diagnosis and management. Cardiol Rev (2009) 0.99
A national survey of cardiovascular physicians' beliefs and clinical care practices when diagnosing and treating depression in patients with cardiovascular disease. Cardiol Rev (2006) 0.99
Safety and immunogenicity of an intranasal Shigella flexneri 2a Invaplex 50 vaccine. Vaccine (2011) 0.98
Endothelin as a clinical target in the treatment of systemic hypertension. Cardiol Rev (2009) 0.98
Experience with faculty supervision of an electronic resident sign-out system. Am J Med (2010) 0.98
Relation of baseline plasma ADMA levels to cardiovascular morbidity and mortality at two years in men with diabetes mellitus referred for coronary angiography. Atherosclerosis (2009) 0.98
Marijuana Use and Cardiovascular Disease. Cardiol Rev (2016) 0.97
Peripartum cardiomyopathy. Cardiol Rev (2005) 0.96
The impact of the food-based and nutrient-based standards on lunchtime food and drink provision and consumption in primary schools in England. Public Health Nutr (2010) 0.96
Evaluating the feasibility of measuring travel to school using a wearable camera. Am J Prev Med (2012) 0.95
Pyrrolidine dithiocarbamate restores endothelial cell membrane integrity and attenuates monocrotaline-induced pulmonary artery hypertension. Am J Physiol Lung Cell Mol Physiol (2008) 0.95
Obesity: new perspectives and pharmacotherapies. Cardiol Rev (2006) 0.95
Cardiac manifestations of sarcoidosis and therapeutic options. Cardiol Rev (2009) 0.94
Health service utilization among Alzheimer's disease patients: evidence from managed care. Alzheimers Dement (2008) 0.94
Laughter-induced syncope. Cardiol Rev (2012) 0.93
Therapeutic angiogenesis: a new treatment approach for ischemic heart disease--part I. Cardiol Rev (2008) 0.93
A multidisciplinary approach for teaching systems-based practice to internal medicine residents. J Grad Med Educ (2011) 0.92
Phytoestrogens as cardioprotective agents. Cardiol Rev (2004) 0.91
Trends in acute kidney injury and outcomes after early percutaneous coronary intervention in patients ≥75 years of age with acute myocardial infarction. Am J Cardiol (2013) 0.90
Compliance with National Cholesterol Education Program dietary and lifestyle guidelines among older women with self-reported hypercholesterolemia. The Women's Health Initiative. Am J Med (2002) 0.90
Effect of modafinil on the pharmacokinetics of ethinyl estradiol and triazolam in healthy volunteers. Clin Pharmacol Ther (2002) 0.90
Cardiovascular pharmacotherapeutic considerations during pregnancy and lactation. Cardiol Rev (2004) 0.90
Short communicationKey differences between school lunches and packed lunches in primary schools in England in 2009. Public Health Nutr (2011) 0.89
Risk factors for appropriate cardioverter-defibrillator shocks, inappropriate cardioverter-defibrillator shocks, and time to mortality in 549 patients with heart failure. Am J Cardiol (2010) 0.89
Valvular heart disease and systemic lupus erythematosus: therapeutic implications. Heart Dis (2003) 0.89
Allopurinol as a cardiovascular drug. Cardiol Rev (2011) 0.89
Cardiovascular pharmacotherapeutic considerations during pregnancy and lactation. Cardiol Rev (2004) 0.89
Role of magnesium in cardiovascular diseases. Cardiol Rev (2014) 0.89
Sutureless mesh-plug femoral hernioplasty. Am J Surg (2003) 0.89
Myotonic dystrophies and the heart. Cardiol Rev (2011) 0.88
Validation of a short food frequency questionnaire to assess folate intake. Br J Nutr (2002) 0.88
Children's lunchtime food choices following the introduction of food-based standards for school meals: observations from six primary schools in Sheffield. Public Health Nutr (2010) 0.88
Remote patient monitoring in chronic heart failure. Cardiol Rev (2013) 0.88
Brown adipose tissue thermogenesis: β3-adrenoreceptors as a potential target for the treatment of obesity in humans. Cardiol Rev (2013) 0.88
Reducing hospital readmissions for cardiovascular disease: is it feasible? Am J Med (2013) 0.88
Use of non-benzodiazepine hypnotics in the elderly: are all agents the same? CNS Drugs (2007) 0.88
Toll-like receptors: new therapeutic targets for the treatment of atherosclerosis, acute coronary syndromes, and myocardial failure. Cardiol Rev (2008) 0.88
Gender, ethnicity and genetics in cardiovascular disease: part 1: Basic principles. Heart Dis (2003) 0.87
Pharmacological inhibition of BLT1 diminishes early abdominal aneurysm formation. Atherosclerosis (2009) 0.87
Chronic renal dysfunction as an independent risk factor for the development of cardiovascular disease. Cardiol Rev (2005) 0.87
The emerging role of apelin in cardiovascular disease and health. Cardiol Rev (2009) 0.87
Urotensin II: a new pharmacologic target in the treatment of cardiovascular disease. Cardiol Rev (2008) 0.86
Sugar and fat intake among children in Scotland: what is needed to reach the dietary targets? Public Health Nutr (2009) 0.86
Comprehensive management of hypertensive emergencies and urgencies. Heart Dis (2002) 0.86
Cardiovascular considerations in patients undergoing gastrointestinal endoscopy. Cardiol Rev (2008) 0.86
Gender effects on cardiac valvular function in hyperprolactinaemic patients receiving cabergoline: a retrospective study. Clin Endocrinol (Oxf) (2009) 0.86
The cardiac ryanodine receptor (RyR2) and its role in heart disease. Cardiol Rev (2005) 0.86
Allergen immunotherapy practice in the United States: guidelines, measures, and outcomes. Ann Allergy Asthma Immunol (2011) 0.86
Cardiac involvement in hemochromatosis. Cardiol Rev (2014) 0.85